# Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)

> **NCT00163449** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00163449
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-11
- **Final completion:** 2007-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2016-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163449, "Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00163449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*